RachaelMorton - International Society of Nephrology Events

Professor of Health Economics, Principal Investigator of the Symptom Monitoring with Feedback Trial (SWIFT), an ANZDATA Registry cluster-randomised trial of electronic patient reported outcome measures among adults receiving haemodialysis.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/62076f9cab32c5cdbfd759fad658a89e.jpg

First name

Rachael

Last name

Morton

Institution

Country

Australia

Thursday, February 6, 2025

Time	Session

2:45 p.m. 4:05 p.m.	ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials SHARE RR2 MegJardine Chair meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia SHARE RR2-001 RachaelMorton Speaker AustraliaNHMRC Clinical Trials Centre, The University of Sydney Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data SHARE RR2-002 Juan-JesusCarrero Speaker SwedenKarolinska Institutet Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK SHARE RR2-003 FergusCaskey Speaker United KingdomUniversity of Bristol, UK Q and A SHARE RR2-004 Kesar Hall 202

Time

Session

2:45 p.m.

4:05 p.m.

ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials

SHARE RR2

MegJardine Chair meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia

Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia

SHARE RR2-001

RachaelMorton Speaker AustraliaNHMRC Clinical Trials Centre, The University of Sydney
Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data

SHARE RR2-002

Juan-JesusCarrero Speaker SwedenKarolinska Institutet
Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK

SHARE RR2-003

FergusCaskey Speaker United KingdomUniversity of Bristol, UK
Q and A

SHARE RR2-004

Kesar Hall 202

RachaelMorton AustraliaNHMRC Clinical Trials Centre, The University of Sydney

Thursday, February 6, 2025